Benzinga | Oct 1, 2021 08:29AM EDT

Medicago To Launch Clinical Trials For COVID-19 Vaccine Candidate With GSK's Pandemic Adjuvant In Japan; Candidate Has Now Completed Enrollment Of Its Phase 2/3 Clinical Trials

-Reuters